CAH · Cardinal Health Inc

Reflects performance share units that will settle on August 15, 2026.

Reflects performance share units that will settle on August 15, 2026.

Reflects performance share units that will settle on August 15, 2026.

Reflects performance share units that will settle on August 15, 2026.

Reflects performance share units that will settle on August 15, 2026.

Reflects performance share units that will settle on August 15, 2026.

Reflects performance share units that will settle on August 15, 2026.

Reflects performance share units that will settle on August 15, 2026.

Price is closing share price on March 20, 2026, which is the date on which Ms. Hemingway Hall was elevated to Chair of the Board.

Ms. Hemingway Hall received a grant of additional RSUs in connection with her elevation to Chair of the Board, effective March 20, 2026.

Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with the vesting of 4,242 restricted share units.

Reflects closing price on prior business day.

Reflects closing price on the date of the grant.

Grant of restricted share units (RSUs) that vest in three equal annual installments beginning on August 15, 2027.

Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with restricted share units.

Price is closing share price on prior business day.

The total number of shares reported as beneficially owned has been adjusted to reflect shares transferred pursuant to a domestic relations order.

Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with restricted share units.

Price is closing share price on prior business day.

Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with restricted share units.

Price is closing share price on prior business day.

Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with restricted share units.

Price is closing share price on prior business day.

Represents withholding of shares to satisfy tax withholding obligations of the reporting person in connection with restricted share units.

Price is closing share price on prior business day.

Grant of restricted share units that will vest on November 5, 2026, except if the 2026 Annual Meeting of Shareholders is prior to November 5, 2026, then the restricted share units will vest on the date of the 2026 Annual Meeting of Shareholders.

Grant of restricted share units that will vest on November 5, 2026, except if the 2026 Annual Meeting of Shareholders is prior to November 5, 2026, then the restricted share units will vest on the date of the 2026 Annual Meeting of Shareholders.

Grant of restricted share units that will vest on November 5, 2026, except if the 2026 Annual Meeting of Shareholders is prior to November 5, 2026, then the restricted share units will vest on the date of the 2026 Annual Meeting of Shareholders.

Grant of restricted share units that will vest on November 5, 2026, except if the 2026 Annual Meeting of Shareholders is prior to November 5, 2026, then the restricted share units will vest on the date of the 2026 Annual Meeting of Shareholders.

Grant of restricted share units that will vest on November 5, 2026, except if the 2026 Annual Meeting of Shareholders is prior to November 5, 2026, then the restricted share units will vest on the date of the 2026 Annual Meeting of Shareholders.

Grant of restricted share units that will vest on November 5, 2026, except if the 2026 Annual Meeting of Shareholders is prior to November 5, 2026, then the restricted share units will vest on the date of the 2026 Annual Meeting of Shareholders.

Grant of restricted share units that will vest on November 5, 2026, except if the 2026 Annual Meeting of Shareholders is prior to November 5, 2026, then the restricted share units will vest on the date of the 2026 Annual Meeting of Shareholders.

Grant of restricted share units that will vest on November 5, 2026, except if the 2026 Annual Meeting of Shareholders is prior to November 5, 2026, then the restricted share units will vest on the date of the 2026 Annual Meeting of Shareholders.

Grant of restricted share units that will vest on November 5, 2026, except if the 2026 Annual Meeting of Shareholders is prior to November 5, 2026, then the restricted share units will vest on the date of the 2026 Annual Meeting of Shareholders.

Grant of restricted share units that will vest on November 5, 2026, except if the 2026 Annual Meeting of Shareholders is prior to November 5, 2026, then the restricted share units will vest on the date of the 2026 Annual Meeting of Shareholders.

Grant of restricted share units that will vest on November 5, 2026, except if the 2026 Annual Meeting of Shareholders is prior to November 5, 2026, then the restricted share units will vest on the date of the 2026 Annual Meeting of Shareholders.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.86 to $149.85, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1 and 2 to this Form 4.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.94 to $150.80, inclusive.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.22 to $151.00, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 1 to this Form 4.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.29 to $149.58, inclusive.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.00 to $148.99, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4 and 5 to this Form 4.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.40 to $149.58, inclusive.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.00 to $149.58, inclusive.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.30 to $149.29, inclusive.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.28 to $149.27, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4 and 5 to this Form 4.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.50 to $149.52, inclusive.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.30 to $149.58, inclusive.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.94 to $149.60, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 4 to this Form 4.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.20 to $149.33, inclusive.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.20 to $149.19, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4 and 5 to this Form 4.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.30 to $148.29, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4, 5, and 6 to this Form 4.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.40 to $148.39, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4, 5, and 6 to this Form 4.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.40 to $149.39, inclusive.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.46 to $149.43, inclusive.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.46 to $148.45, inclusive. The reporting person undertakes to provide to Cardinal Health, Inc., any security holder of Cardinal Health, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 4, 5, and 6 to this Form 4.